/PRNewswire/ Menarini Silicon Biosystems (MSB), a pioneer of single cell technologies, announced today its new FFPE Rescue Application, to enable molecular.
Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB s DEPArray technology to successfully recover low numbers of tumor cells from these difficult samples. The new FFPE Rescue Application will provide pathology labs with a validated workflow to identify potentially targetable mutations in more FFPEbiopsy samples.
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 16, 2021 /PRNewswire/ Menarini Silicon Biosystems (MSB), a pioneer of single cell technologies, announced today its new FFPE Rescue Application, to enable molecular testing on formalin-fixed, paraffin-embedded (FFPE) samples with low tumor cell contents. Thanks to the sorting capabilities of the recently launched DEPArray PLUS instrument, it is possible to isolate a sufficient number of tumor cells to generate relevant molecular data, even from FFPE tissues that were previously discarded from conventional Next Generation Sequencing (NGS)
/PRNewswire/ Menarini Silicon Biosystems (MSB), a pioneer of single cell technologies, announced today its new FFPE Rescue Application, to enable molecular.